Pegram, Mark http://orcid.org/0000-0002-9743-8118
Jackisch, Christian http://orcid.org/0000-0001-8537-3743
Johnston, Stephen R. D.
Article History
Received: 2 March 2022
Accepted: 4 April 2023
First Online: 31 May 2023
Competing interests
: The authors declare the following competing interests: MP has served as a consultant for Roche/Genentech, AstraZeneca, Novartis, Pfizer, Seattle Genetics. CJ has served as a consultant for Roche, AstraZeneca, Pfizer, Celgene, Exact Sciences, Lilly, Pierre Fabre, and Sanofi Genzyme; has presented on behalf of Roche, AstraZeneca, Pfizer, Celgene, Exact Sciences, Novartis, Lilly, and medupdate GmbH; and has received research funding from Exact Sciences and Roche. SRDJ has served as a consultant for Lilly, Puma Biotechnology, Pfizer, Novartis, and Sanofi Genzyme; has presented on behalf of Pfizer, Novartis, Eisai, Lilly, AstraZeneca, Roche/Genentech, and Sanofi Genzyme; and has received research funding from Lilly, Pfizer, AstraZeneca, Novartis, Roche/Genentech, and Puma Biotechnology.